| Thomas Knauss, MD | |
|
11100 Euclid Avenue, Cleveland, OH 44106 | |
| (216) 844-8500 | |
| Not Available |
| Full Name | Thomas Knauss |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 11100 Euclid Avenue, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629098389 | NPI | - | NPPES |
| 363714 | Other | OH | WELLCARE |
| 000000539576 | Other | OH | ANTHEM |
| 000000224292 | Other | OH | UNISON |
| 0764641 | Medicaid | OH | |
| 0651227 | Other | OH | AETNA |
| 741803 | Other | BUCKEYE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 35-052299 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Knauss, MD 3605 Warrensville Center Rd, 1st Floor, Shaker Heights, OH 44122 Ph: (216) 286-6295 | Thomas Knauss, MD 11100 Euclid Avenue, Cleveland, OH 44106 Ph: (216) 844-8500 |
News Archive
The U.S. Food and Drug Administration today approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in certain adults.
Health IT connectivity leader VisionShare® Inc. announces it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions and indicates compliance with industry-established standards and HIPAA regulations.
The Defense Advanced Research Projects Agency (DARPA), the research arm of the U.S. Department of Defense, has awarded Duke University $19.5 million for an effort led by the Duke Institute for Genome Sciences & Policy (IGSP) to design a portable, easy-to-use diagnostic device that can reveal who is infected with an upper respiratory virus before the first cough or sneeze.
An enzyme implicated in osteoporosis, arthritis, atherosclerosis and cancer metastasis - cathepsin K - eluded reliable detection in laboratory experiments in the past. Now, a research team at the Georgia Institute of Technology has developed an assay that reliably detects and quantifies mature cathepsin K using a technique called gelatin zymography.
The lawsuit challenges Medicare's use of this practice, which classifies certain hospital patients as not having been formally admitted for billing purposes, even though they might have been in the hospital for days.
› Verified 8 days ago
Amir Razavi, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Dr. Francois Fadell, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 18200 Lorain Ave, Moll Cancer Center At Fairview- Respiratory Institute, Cleveland, OH 44111 Phone: 216-444-6503 | |
Sana Hasan, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195 Phone: 330-721-5700 | |
Catherine Frakes Vozzo, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-4444 Fax: 216-445-6290 | |
Tarek Ashour, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q7, Cleveland, OH 44195 Phone: 216-444-5040 | |
Mrs. Efewongbe Benedicta Oleghe, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2351 E 22nd Street, St Vincent's Charity Medical Center, Cleveland, OH 44115 Phone: 216-363-2725 | |
Dr. Toufik Z. Madhun, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave Dept Of, Cleveland, OH 44106 Phone: 216-844-1000 |